What You May Have Missed in 2024 - Part 2

What You May Have Missed in 2024 - Part 2

Up next

Carvedilol Versus Other Nonselective Beta-Blockers in Cirrhosis

Dr. Centor discusses the use of carvedilol in patients with cirrhosis with Drs. Kueiyu Joshua Lin and Tracey G. Simon. 

Tirzepatide Versus Intensified Conventional Care for Poorly Controlled Type 2 Diabetes

Dr. Centor discusses the use of tirzepatide in the treatment of type 2 diabetes with Dr. Bryan Batch. 

Recommended Episodes

2024 Year in Review
Critical Matters

This episode of Critical Matters will close 2024 with a year in review. Dr. Sergio Zanotti is going solo and will discuss a couple of relevant clinical guidelines and review five clinical trials. To close, he'll share some of his favorite books for 2024. Additional Resources: Cri ...  Show more

JACC - December 17 - 24, 2024 Issue Summary
JACC This Week

In this episode, Dr. Valentin Fuster highlights five cutting-edge cardiology studies from the December 2024 issue of JACC, covering topics such as cardiac MRI's role in predicting sudden cardiac events in Fontan patients, the impact of oxidized phospholipids on calcific aortic va ...  Show more

Best Moments of 2018 You May Have Missed – Part 1
Something You Should Know

With over 100 episodes a year, it is entirely possible you may have missed some of the best, most interesting moments of the past year. Or perhaps you may have forgotten some interesting intel you learned. So here are some highlights from 2018.  Learn more about your ad choices. ...  Show more